We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+8.25%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$107B
AUM Growth
+$9.22B
Cap. Flow
+$1.49B
Cap. Flow %
1.39%
Top 10 Hldgs %
13.06%
Holding
11,531
New
1,148
Increased
4,823
Reduced
3,924
Closed
1,123

Sector Composition

Rank Sector Weight
1 Energy 8.45%
2 Healthcare 6.45%
3 Technology 6.41%
4 Financials 6.11%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OVTI
4026
PUT
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
$642K ﹤0.01%
37,300
+30,200
+425% +$458K
MCP
4027
PUT
DELISTED
MOLYCORP INC COM STK
MCP
$642K ﹤0.01%
114,300
-2,400
-2% -$12.7K
EQY
4028
DELISTED
Equity One
EQY
$640K ﹤0.01%
28,533
+13,057
+84% +$297K
BCRX icon
4029
BioCryst Pharmaceuticals
BCRX
$2.35B
$639K ﹤0.01%
84,132
-38,352
-31% -$243K
HPY
4030
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
$639K ﹤0.01%
12,818
-2,544
-17% -$110K
FAM
4031
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
$638K ﹤0.01%
45,441
-6,338
-12% -$89.9K
AWAY
4032
CALL
DELISTED
HOMEAWAY INC COM
AWAY
$638K ﹤0.01%
15,600
+12,300
+373% +$419K
IDIX
4033
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$638K ﹤0.01%
106,744
-402
-0.4% -$1.86K
FXC icon
4034
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.2M
$637K ﹤0.01%
6,800
+5,800
+580% +$550K
TJX icon
4035
PUT
TJX Companies
TJX
$176B
$637K ﹤0.01%
20,000
+13,600
+213% +$412K
SSO icon
4036
PUT
ProShares Ultra S&P500
SSO
$7.76B
$636K ﹤0.01%
99,200
-190,400
-66% -$1.12M
PER
4037
DELISTED
SANDRIDGE PERMIAN TRUST
PER
$636K ﹤0.01%
53,697
-2,355
-4% -$31.9K
PBF icon
4038
CALL
PBF Energy
PBF
$8.65B
$635K ﹤0.01%
20,200
-16,100
-44% -$439K
IGA
4039
Voya Global Advantage and Premium Opportunity Fund
IGA
$156M
$634K ﹤0.01%
53,928
-3,689
-6% -$43.6K
SNDA icon
4040
Sonida Senior Living
SNDA
$1.9B
$634K ﹤0.01%
1,762
+1,441
+449% +$480K
JNS
4041
DELISTED
Janus Capital Group Inc
JNS
$634K ﹤0.01%
51,243
-165,041
-76% -$1.7M
SQM icon
4042
Sociedad Química y Minera de Chile
SQM
$19.5B
$632K ﹤0.01%
25,080
-10,678
-30% -$276K
IIP
4043
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$632K ﹤0.01%
83,938
+7,876
+10% +$59.3K
DTRE icon
4044
First Trust Alerian Disruptive Technology Real Estate ETF
DTRE
$14.9M
$631K ﹤0.01%
16,094
+596
+4% +$23.8K
SMFG icon
4045
Sumitomo Mitsui Financial
SMFG
$164B
$631K ﹤0.01%
60,129
+12,169
+25% +$121K
HBNK
4046
DELISTED
HAMPDEN BANCORP INC COM STK (DELAWARE)
HBNK
$631K ﹤0.01%
38,459
-28,731
-43% -$479K
ENX
4047
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$630K ﹤0.01%
55,659
+22,435
+68% +$254K
LH icon
4048
CALL
Labcorp
LH
$25.9B
$630K ﹤0.01%
+8,032
New +$685K
FCO
4049
DELISTED
abrdn Global Income Fund
FCO
$629K ﹤0.01%
60,442
-9,626
-14% -$104K
MGLN
4050
DELISTED
Magellan Health Services, Inc.
MGLN
$629K ﹤0.01%
10,497
-6,336
-38% -$378K

Similar funds

UBS's Q4 2013 Portfolio in Review

As of Q4 2013, UBS held 11,531 positions worth $107B, up 9.4% from $97.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS's Q4 2013 filing shows 1,148 new, 4,823 increased, 3,924 reduced and 1,123 closed positions. Its largest new stake was American Airlines Group: 670,542 shares worth $16.9M. The largest sale was TALISMAN ENERGY INC, an estimated $615M.

By sector, the portfolio is most concentrated in Energy at 8.5% of assets, down from 9.1% a quarter earlier, followed by Healthcare and Technology.

  • UBS's largest Q4 2013 buy was American Airlines Group: 670,542 shares worth $16.9M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $1.56B increase.
  • UBS's biggest Q4 2013 reduction was TALISMAN ENERGY INC, cutting an estimated $615M.
  • UBS fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $110M.
  • UBS's ten largest holdings make up 13% of its $107B portfolio in Q4 2013.
  • UBS opened 1,148 new positions and closed 1,123 in Q4 2013.
  • UBS's portfolio value rose 9.4% quarter-over-quarter to $107B.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.